{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:19:00Z","timestamp":1791361140951,"version":"4.3.1"},"reference-count":78,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Endothelial dysfunction is a recognized component of the pathogenesis and clinical course of inflammatory bowel disease (IBD). Measurement of soluble forms of cell adhesion molecules (CAMs) may reflect the extent of endothelial injury and serve as potential biomarkers of disease activity. We conducted a systematic review and meta-analysis of studies reporting soluble intercellular adhesion molecule\u22121 (sICAM\u22121), vascular cell adhesion molecule\u22121 (sVCAM\u22121), mucosal addressin cell adhesion molecule\u22121 (sMAdCAM\u22121), and selectins (sE\u2212selectin, sP\u2212selectin, and sL\u2212selectin) in patients with IBD and healthy controls, or in comparable IBD subgroups defined by disease activity or type.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We systematically searched PubMed, Embase, Web of Science, and Scopus from inception to June 15, 2025. Risk of bias was assessed using a modified Newcastle\u2013Ottawa Scale.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twenty-six studies met the inclusion criteria. Compared with healthy controls, patients with IBD showed higher levels of sICAM-1 (SMD 1.38, 95% CI 0.51 to 2.25, p=0.002) and sE-selectin (SMD 0.35, 95% CI 0.09 to 0.61, p=0.008). In subgroup analyses, this association persisted for sICAM-1 in both Crohn\u2019s disease (CD) (SMD 1.89, 95% CI 0.15 to 3.62, p=0.033) and ulcerative colitis (UC) (SMD 0.95, 95% CI 0.25 to 1.64, p=0.008), and for sE-selectin only in CD (SMD 0.43, 95% CI 0.04 to 0.82, p=0.032). When comparing active and inactive disease, higher sICAM-1 levels were observed in the active group (SMD 0.75, 95% CI 0.38 to 1.12, p&amp;lt;0.001), while no significant differences were found for other CAMs. No differences in levels of these molecules were observed between CD and UC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Circulating CAMs, particularly sICAM-1 and sE-selectin, are elevated in IBD patients, supporting a role of endothelial injury in disease pathogenesis. Among these, sICAM-1 shows potential as a biomarker for distinguishing active from inactive disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic Review Registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/<\/jats:ext-link>\n                      , identifier CRD420251088622.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1680317","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T05:17:03Z","timestamp":1764566223000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Circulating cell adhesion molecules as biomarkers in inflammatory bowel disease: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"16","author":[{"given":"Krzysztof","family":"Prz\u0119czek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Cibor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Zwoli\u0144ska-Wcis\u0142o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danuta","family":"Owczarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i1.91","article-title":"Inflammatory bowel disease: pathogenesis","volume":"20","author":"Zhang","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ecco-jcc\/jjad108","article-title":"ECCO guidelines on extraintestinal manifestations in inflammatory bowel disease","volume":"18","author":"Gordon","year":"2024","journal-title":"J Crohns Colitis"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/nu14214622","article-title":"The importance of nutritional aspects in the assessment of inflammation and intestinal barrier in patients with inflammatory bowel disease","volume":"14","author":"Kaczmarczyk","year":"2022","journal-title":"Nutrients"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.20452\/pamw.15999","article-title":"Serum levels of selected micronutrients in patients with inflammatory bowel disease in clinical remission","volume":"131","author":"Pi\u0105tek-Guziewicz","year":"2021","journal-title":"Pol Arch Intern Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1234535","article-title":"Cutaneous manifestations of inflammatory bowel disease: basic characteristics, therapy, and potential pathophysiological associations","volume":"14","author":"He","year":"2023","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3748\/wjg.v20.i1.53","article-title":"Inflammatory bowel disease: epidemiology, pathology and risk factors for hypercoagulability","volume":"20","author":"Owczarek","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e065186","DOI":"10.1136\/bmjopen-2022-065186","article-title":"Global, regional and national burden of inflammatory bowel disease in 204 countries and territories from 1990 to 2019: a systematic analysis based on the Global Burden of Disease Study 2019","volume":"13","author":"Wang","year":"2023","journal-title":"BMJ Open"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i3.1067","article-title":"Endothelial dysfunction in inflammatory bowel diseases: Pathogenesis, assessment and implications","volume":"22","author":"Cibor","year":"2016","journal-title":"World J Gastroenterol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232012445","article-title":"Etiology of IBD-is it still a mystery","volume":"23","author":"Kofla-D\u0142ubacz","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000131515.03336.f8","article-title":"Role of endothelial dysfunction in atherosclerosis","volume":"109","author":"Davignon","year":"2004","journal-title":"Circulation"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.117.309813","article-title":"Endothelial functions","volume":"37","author":"Godo","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.20452\/pamw.4232","article-title":"Endothelium, asymmetric dimethylarginine, and atherosclerosis in chronic kidney disease","volume":"128","author":"Ma\u0142yszko","year":"2018","journal-title":"Pol Arch Intern Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"598","DOI":"10.20452\/pamw.15463","article-title":"Serum concentration of selected biochemical markers of endothelial dysfunction and inflammation in patients with the varying activity of inflammatory bowel disease","volume":"130","author":"Cibor","year":"2020","journal-title":"Pol Arch Intern Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1136\/gut.2010.207480","article-title":"Role of the vascular and lymphatic endothelium in the pathogenesis of inflammatory bowel disease: 'brothers in arms'","volume":"60","author":"Danese","year":"2011","journal-title":"Gut"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.cellbio.042308.113238","article-title":"Rolling cell adhesion","volume":"26","author":"McEver","year":"2010","journal-title":"Annu Rev Cell Dev Biol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvv154","article-title":"Selectins: initiators of leucocyte adhesion and signalling at the vascular wall","volume":"107","author":"McEver","year":"2015","journal-title":"Cardiovasc Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.2MR0220-549R","article-title":"ICAM-1: A master regulator of cellular responses in inflammation, injury resolution, and tumorigenesis","volume":"108","author":"Bui","year":"2020","journal-title":"J Leukoc Biol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2023.117487","article-title":"ICAM-1 and VCAM-1: Gatekeepers in various inflammatory and cardiovascular disorders","volume":"548","author":"Singh","year":"2023","journal-title":"Clin Chim Acta"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00903","article-title":"MAdCAM-1-mediated intestinal lymphocyte homing is critical for the development of active experimental autoimmune encephalomyelitis","volume":"10","author":"Kuhbandner","year":"2019","journal-title":"Front Immunol"},{"key":"B20","first-page":"97","article-title":"Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue","volume":"151","author":"Briskin","year":"1997","journal-title":"Am J Pathol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2021.166170","article-title":"VCAM-1 as a predictor biomarker in cardiovascular disease","volume":"1867","author":"Troncoso","year":"2021","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1438302","article-title":"Circulating cell adhesion molecules in systemic sclerosis: a systematic review and meta-analysis","volume":"15","author":"Mangoni","year":"2024","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/cc13733","article-title":"Soluble adhesion molecules as markers for sepsis and the potential pathophysiological discrepancy in neonates, children and adults","volume":"18","author":"Zonneveld","year":"2014","journal-title":"Crit Care"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-03-743211","article-title":"Cancer-associated pathways and biomarkers of venous thrombosis","volume":"130","author":"Hisada","year":"2017","journal-title":"Blood"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3163\/1536-5050.104.3.014","article-title":"De-duplication of database search results for systematic reviews in EndNote","volume":"104","author":"Bramer","year":"2016","journal-title":"J Med Libr Assoc"},{"key":"B27","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12874-024-02356-6","article-title":"Meta-analysis accelerator: a comprehensive tool for statistical data conversion in systematic reviews with meta-analysis","volume":"24","author":"Abbas","year":"2024","journal-title":"BMC Med Res Methodol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"B29","volume-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"Wells","year":"2013"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2023.1241422","article-title":"Vascular-related biomarkers in psychosis: a systematic review and meta-analysis","volume":"14","author":"Li","year":"2023","journal-title":"Front Psychiatry"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-11-41","article-title":"Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics","volume":"11","author":"Bowden","year":"2011","journal-title":"BMC Med Res Methodol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"B33","volume-title":"Cochrane handbook for systematic reviews of interventions version 6.5","author":"Higgins","year":"2024"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/s0895-4356(01)00377-8","article-title":"Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis","volume":"54","author":"Sterne","year":"2001","journal-title":"J Clin Epidemiol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/j.0006-341x.2000.00455.x","article-title":"Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1136\/gut.34.11.1593","article-title":"Expression of intercellular adhesion molecule 1 (ICAM-1, CD54) in colonic epithelial cells","volume":"34","author":"Dippold","year":"1993","journal-title":"Gut"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1155\/S096293519400030X","article-title":"Serum concentration and chemotactic activity of E-selectin (CD62E) in inflammatory bowel disease","volume":"3","author":"Vainer","year":"1994","journal-title":"Mediators Inflammation"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/BF02088125","article-title":"Circulating soluble intercellular adhesion molecule-1 (sICAM-1) in active inflammatory bowel disease","volume":"39","author":"Nielsen","year":"1994","journal-title":"Dig Dis Sci"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1136\/gut.36.5.724","article-title":"Adhesion molecules in inflammatory bowel disease","volume":"36","author":"Jones","year":"1995","journal-title":"Gut"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199511000-00005","article-title":"Circulating soluble adhesion molecules in inflammatory bowel disease","volume":"7","author":"Patel","year":"1995","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/BF02934086","article-title":"Elevated serum concentrations of soluble selectin and immunoglobulin type adhesion molecules in patients with inflammatory bowel disease","volume":"32","author":"G\u00f6ke","year":"1997","journal-title":"J Gastroenterol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1136\/gut.43.1.40","article-title":"Visualising E-selectin in the detection and evaluation of inflammatory bowel disease","volume":"43","author":"Bhatti","year":"1998","journal-title":"Gut"},{"key":"B45","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1023\/a:1018875410987","article-title":"Expression of E-selectin, sialyl Lewis X, and macrophage inflammatory protein-1alpha by colonic epithelial cells in ulcerative colitis","volume":"43","author":"Vainer","year":"1998","journal-title":"Dig Dis Sci"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.538_f.x","article-title":"Circulating L-selectin levels and endothelial CD34 expression in inflammatory bowel disease","volume":"93","author":"Seidelin","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/s000110050618","article-title":"Expression of platelet P-selectin and detection of soluble P-selectin, NPY and RANTES in patients with inflammatory bowel disease","volume":"49","author":"F\u00e4gerstam","year":"2000","journal-title":"Inflammation Res"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1007\/BF03168821","article-title":"Soluble adhesion molecules in inflammatory bowel disease","volume":"170","author":"Goggins","year":"2001","journal-title":"Ir J Med Sci"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1080\/00365520310000609a","article-title":"Correlation between circulating soluble ICAM-1 and prednisolone-induced amelioration of ulcerative colitis","volume":"38","author":"Vainer","year":"2003","journal-title":"Scand J Gastroenterol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1023\/b:ddas.0000037822.55717.31","article-title":"Soluble selectins, sICAM, sVCAM, and angiogenic proteins in different activity groups of patients with inflammatory bowel disease","volume":"49","author":"Magro","year":"2004","journal-title":"Dig Dis Sci"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200411000-00011","article-title":"Association between enhanced soluble CD40 ligand and prothrombotic state in inflammatory bowel disease","volume":"16","author":"Koutroubakis","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.50381.x","article-title":"Elevated circulating platelet-derived microparticles in patients with active inflammatory bowel disease","volume":"100","author":"Andoh","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20655","article-title":"Increased circulating platelet-neutrophil, platelet-monocyte complexes, and platelet activation in patients with ulcerative colitis: a comparative study","volume":"81","author":"Pamuk","year":"2006","journal-title":"Am J Hematol"},{"key":"B54","first-page":"37","article-title":"Clinical significance of intercellular adhesion molecule-1 in ulcerative colitis","volume":"93","author":"Ogawa","year":"2008","journal-title":"Int Surg"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.15.3916","article-title":"Soluble intercellular adhesion molecule-1, D-lactate and diamine oxidase in patients with inflammatory bowel disease","volume":"15","author":"Song","year":"2009","journal-title":"World J Gastroenterol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.5603\/fhc.2011.0017","article-title":"Assessment of the influence of the inflammatory process on the activation of blood platelets and morphological parameters in patients with ulcerative colitis (colitis ulcerosa)","volume":"49","author":"Poli\u0144ska","year":"2011","journal-title":"Folia Histochem Cytobiol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjx049","article-title":"Candidate serum markers in early crohn's disease: predictors of disease course","volume":"11","author":"Smids","year":"2017","journal-title":"J Crohns Colitis"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000991","article-title":"Serum amyloid A as a surrogate marker for mucosal and histologic inflammation in patients with crohn's disease","volume":"23","author":"Yarur","year":"2017","journal-title":"Inflammation Bowel Dis"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000001002","article-title":"Inflammatory cytokine profile in crohn's disease nonresponders to optimal antitumor necrosis factor therapy","volume":"53","author":"Yarur","year":"2019","journal-title":"J Clin Gastroenterol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"28055","DOI":"10.1038\/s41598-024-78462-8","article-title":"Platelet activation through CD62P and the formation of platelet-monocyte complexes are associated with the exacerbation of mucosal inflammation in patients with ulcerative colitis","volume":"14","author":"Sano","year":"2024","journal-title":"Sci Rep"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25073564","article-title":"A prospective observational study analyzing the diagnostic value of hepcidin-25 for anemia in patients with inflammatory bowel diseases","volume":"25","author":"Petrovi\u0107","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3390\/app14135434","article-title":"Serum profiling of proinflammatory mediators in inflammatory bowel disease: indication for use in differential diagnosis","volume":"14","author":"G\u00f3recka","year":"2024","journal-title":"Appl Sci"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/nri2156","article-title":"Getting to the site of inflammation: the leukocyte adhesion cascade updated","volume":"7","author":"Ley","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.devcel.2014.05.002","article-title":"Distinct chemokine signaling regulates integrin ligand specificity to dictate tissue-specific lymphocyte homing","volume":"30","author":"Sun","year":"2014","journal-title":"Dev Cell"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01078","article-title":"Cell adhesion molecules and their roles and regulation in the immune and tumor microenvironment","volume":"10","author":"Harjunp\u00e4\u00e4","year":"2019","journal-title":"Front Immunol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1395714","article-title":"The role of galectins in mediating the adhesion of circulating cells to vascular endothelium","volume":"15","author":"Souchak","year":"2024","journal-title":"Front Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00552.2003","article-title":"The vascular contribution in the pathogenesis of inflammatory bowel disease","volume":"285","author":"Hatoum","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1136\/gut.36.3.411","article-title":"Increased expression of cell adhesion molecule P-selectin in active inflammatory bowel disease","volume":"36","author":"Sch\u00fcrmann","year":"1995","journal-title":"Gut"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25122835","article-title":"Selectins-the two dr. Jekyll and mr. Hyde faces of adhesion molecules-A review","volume":"25","author":"Tvaro\u0161ka","year":"2020","journal-title":"Molecules"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2011.168559","article-title":"Circulating soluble intercellular adhesion molecule 1 and subclinical atherosclerosis: the Coronary Artery Risk Development in Young Adults Study","volume":"58","author":"Gross","year":"2012","journal-title":"Clin Chem"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/331041a0","article-title":"A tissuespecific endothelial cell molecule involved in lymphocyte homing","volume":"331","author":"Streeter","year":"1988","journal-title":"Nature"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjac182","article-title":"Mucosal addressin cell adhesion molecule 1 expression reflects mucosal inflammation and subsequent relapse in patients with ulcerative colitis","volume":"17","author":"Uchiyama","year":"2023","journal-title":"J Crohns Colitis"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1177\/1756284820971214","article-title":"Biomarkers are associated with clinical and endoscopic outcomes with vedolizumab treatment in Crohn's disease","volume":"13","author":"Holmer","year":"2020","journal-title":"Therap Adv Gastroenterol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izy307","article-title":"Biomarkers are associated with clinical and endoscopic outcomes with vedolizumab treatment in ulcerative colitis","volume":"25","author":"Battat","year":"2019","journal-title":"Inflammation Bowel Dis"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjaa239","article-title":"Tissue Exposure does not Explain Non-Response in Ulcerative Colitis Patients with Adequate Serum Vedolizumab Concentrations","volume":"15","author":"Van Den Berghe","year":"2021","journal-title":"J Crohns Colitis"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.18999\/nagjms.86.3.407","article-title":"Predictors of the efficacy of vedolizumab in patients with ulcerative colitis","volume":"86","author":"Kajikawa","year":"2024","journal-title":"Nagoya J Med Sci"},{"key":"B77","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000500721","article-title":"Mechanism-based treatment strategies for IBD: cytokines, cell adhesion molecules, JAK inhibitors, gut flora, and more","volume":"4","author":"Schreiner","year":"2019","journal-title":"Inflammation Intest Dis"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.656452","article-title":"Targeting immune cell trafficking - insights from research models and implications for future IBD therapy","volume":"12","author":"Wiendl","year":"2021","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1680317\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T05:17:05Z","timestamp":1764566225000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1680317\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":78,"alternative-id":["10.3389\/fimmu.2025.1680317"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1680317","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"article-number":"1680317"}}